Future studies examining mitophagy flux, mitochondrial membrane potential, mtROS levels, and autophagy marker dynamics will be essential to clarify whether TRIP13 influences mitochondrial quality control in ccRCC or acts through alternative metabolic or signaling pathways. The gene discussed is TRIP13; the disease is nonpapillary renal cell carcinoma.